FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Philip Poole-Wilson

Research Profile

Disorders

Chemicals & Drugs

Procedures

Anatomy

Myocardium

Concepts & Ideas

Physiology

Oxygen Consumption

Co-author Network

Publications

TOP 3
Konstantinos Dimopoulos; Darrel P Francis; Isaac Bendayan; Nicky Best; Gerhard-Paul Diller; Georgios Giannakoulas; Emmanouil Liodakis; Michael Mullen; Ricardo Petraco; Massimo F Piepoli; Philip A Poole-Wilson; Michael B Rubens; Lorna Swan; Michael A Gatzoulis
Cardiothoracic ratio from postero-anterior chest radiographs: A simple, reproducible and independent marker of disease severity and outcome in adults with congenital heart disease.
Darlington O Okonko; Philip A Poole-Wilson; Stefan D Anker; Stephen B Marley; Myrtle Y Gordon
Erythropoietin resistance contributes to anaemia in chronic heart failure and relates to aberrant JAK-STAT signal transduction.
Stephan von Haehling; Andrew J S Coats; Wolfram Doehner; Günter Fauler; Ewa Jankowska; Paul R Kalra; Piotr Ponikowski; Philip A Poole-Wilson; Anja Sandek; Joerg C Schefold; Jochen Springer; Tatjana Stojakovic; Michael Trauner; Ali Vazir; Hans-Dieter Volk; Stefan D Anker
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Philip Poole-Wilson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Konstantinos Dimopoulos; Darrel P Francis; Isaac Bendayan; Nicky Best; Gerhard-Paul Diller; Georgios Giannakoulas; Emmanouil Liodakis; Michael Mullen; Ricardo Petraco; Massimo F Piepoli; Philip A Poole-Wilson; Michael B Rubens; Lorna Swan; Michael A Gatzoulis
Cardiothoracic ratio from postero-anterior chest radiographs: A simple, reproducible and independent marker of disease severity and outcome in adults with congenital heart disease.
International journal of cardiology 2013;166(2):453-7.
2013: Darlington O Okonko; Philip A Poole-Wilson; Stefan D Anker; Stephen B Marley; Myrtle Y Gordon
Erythropoietin resistance contributes to anaemia in chronic heart failure and relates to aberrant JAK-STAT signal transduction.
International journal of cardiology 2013;164(3):359-64.
2012: Stephan von Haehling; Andrew J S Coats; Wolfram Doehner; Günter Fauler; Ewa Jankowska; Paul R Kalra; Piotr Ponikowski; Philip A Poole-Wilson; Anja Sandek; Joerg C Schefold; Jochen Springer; Tatjana Stojakovic; Michael Trauner; Ali Vazir; Hans-Dieter Volk; Stefan D Anker
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.
Journal of the American College of Cardiology 2012;59(6):585-92.
2012: Rajaa F Faris; Marcus Flather; Philip A Poole-Wilson; Henry Purcell; Andrew J S Coats
Diuretics for heart failure.
Cochrane database of systematic reviews (Online) 2012;2():CD003838.
2011: Ravi G Assomull; William M Bradlow; Martin R Cowie; Ankur Gulati; Paul R Kalra; Jennifer Keegan; Lloyd William guy; Jonathan Lyne; Dudley J Pennell; Philip A Poole-Wilson; Carl Shakespeare; Julian Strange; Sanjay K Prasad
Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology.
Circulation 2011;124(12):1351-60.
2011: Darlington O Okonko; Amit K J Mandal; Constantinos G Missouris; Philip A Poole-Wilson
Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival.
Journal of the American College of Cardiology 2011;58(12):1241-51.
2011: Hitesh Patel; Mitesh Patel; Philip A Poole-Wilson; Baris A Ozdemir; Han B Xiao; Stuart D Rosen
Impairment of autonomic reactivity is a feature of heart failure whether or not the left ventricular ejection fraction is normal.
International journal of cardiology 2011;151(1):34-9.
2011: Alexander R Lyon; Kenneth T MacLeod; Peter O'Gara; Emma Pearce; Nicholas S Peters; Philip A Poole-Wilson; Amir H Sepehripour; Mark L Bannister; Tom Collins; Sukhpreet S Dubb; Edwin Garcia; Roger J Hajjar; Erik Kohlbrenner; Lifan Liang; Sian E Harding
SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure.
Circulation. Arrhythmia and electrophysiology 2011;4(3):362-72.
2010: Ewa Jankowska; Anna Drohomirecka; Beata Ponikowska; Agnieszka Witkowska; Monika Lopuszanska; Alicja Szklarska; Ludmila Borodulin-Nadzieja; Waldemar Banasiak; Philip A Poole-Wilson; Piotr Ponikowski
Deficiencies in circulating testosterone and dehydroepiandrosterone sulphate, and depression in men with systolic chronic heart failure.
European journal of heart failure 2010;12(9):966-73.
2010: Konstantinos Dimopoulos; Gerhard-Paul Diller; Ricardo Petraco; Evdokia Koltsida; Georgios Giannakoulas; Edgar Lik Tay; Nicky Best; Massimo F Piepoli; Darrel P Francis; Philip A Poole-Wilson; Michael A Gatzoulis
Hyponatraemia: A strong predictor of mortality in adults with congenital heart disease.
European heart journal 2010;31(5):595-601.
2010: Peter C Hastings; Ali Vazir; Guy E Meadows; Mark Dayer; Philip A Poole-Wilson; Hugh F McIntyre; Mary J Morrell; Martin R Cowie; Anita K Simonds
Adaptive servo-ventilation in heart failure patients with sleep apnea: a real world study.
International journal of cardiology 2010;139(1):17-24.
2010: Zoltán Vokó; Nicolas Danchin; Sophie de Brouwer; Bridget-Anne Kirwan; Philip A Poole-Wilson; Jacobus Lubsen
Correlates of coronary angiography in patients with stable angina and geographical differences in its utilisation: the ACTION experience.
International journal of cardiology 2010;138(1):56-62.
2010: Paul R Kalra; Jonathan R Clague; Andrew J Coats; Stefan D Anker; Philip A Poole-Wilson; Allan D Struthers
C-type natriuretic peptide production by the human kidney is blunted in chronic heart failure.
Clinical science (London, England : 1979) 2010;118(1):71-7.
2009: Stefan D Anker; Josep Comin Colet; Gerasimos Filippatos; Ronnie Willenheimer; Kenneth Dickstein; Helmut Drexler; Thomas F Lüscher; Boris Bart; Waldemar Banasiak; Joanna Niegowska; Bridget-Anne Kirwan; Claudio Mori; Barbara von Eisenhart Rothe; Stuart J Pocock; Philip A Poole-Wilson; Piotr Ponikowski
Ferric carboxymaltose in patients with heart failure and iron deficiency.
The New England journal of medicine 2009;361(25):2436-48.
2009: Marvin A Konstam; James D Neaton; Kenneth Dickstein; Helmut Drexler; Michel Komajda; Felipe A Martinez; Gunter A J Riegger; William Malbecq; Ronald D Smith; Soneil Guptha; Philip A Poole-Wilson
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.
Lancet 2009;374(9704):1840-8.
2009: Konstantinos Dimopoulos; Gerhard-Paul Diller; Georgios Giannakoulas; Ricardo Petraco; Aikaterini Chamaidi; Evaggelia Karaoli; Michael J Mullen; Lorna Swan; Massimo F Piepoli; Philip A Poole-Wilson; Darrel P Francis; Michael A Gatzoulis
Anemia in adults with congenital heart disease relates to adverse outcome.
Journal of the American College of Cardiology 2009;54(22):2093-100.
2009: Stefan D Anker; Josep Comin Colet; Gerasimos Filippatos; Ronnie Willenheimer; Kenneth Dickstein; Helmut Drexler; Thomas F Lüscher; Claudio Mori; Barbara von Eisenhart Rothe; Stuart Pocock; Philip A Poole-Wilson; Piotr Ponikowski
Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia.
European journal of heart failure 2009;11(11):1084-91.
2009: Wayne C Levy; Kerry L Lee; Anne S Hellkamp; Jeanne E Poole; Dariush Mozaffarian; David T Linker; Aldo P Maggioni; Inder Anand; Philip A Poole-Wilson; Daniel P Fishbein; George Johnson; Jill Anderson; Daniel B Mark; Gust H Bardy
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population.
Circulation 2009;120(10):835-42.
2009: Dirk J van Veldhuisen; Alain Cohen-Solal; Michael Böhm; Stefan D Anker; Daphne Babalis; Michael Roughton; Andrew J S Coats; Philip A Poole-Wilson; Marcus D Flather
Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
Journal of the American College of Cardiology 2009;53(23):2150-8.
2009: Ewa Jankowska; Gerasimos Filippatos; Beata Ponikowska; Ludmila Borodulin-Nadzieja; Stefan D Anker; Waldemar Banasiak; Philip A Poole-Wilson; Piotr Ponikowski
Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure.
Journal of cardiac failure 2009;15(5):442-50.
2009: Ewa Jankowska; Piotr Rozentryt; Beata Ponikowska; Oliver Hartmann; Dorota Kustrzycka-Kratochwil; Krzysztof Reczuch; Jolanta Nowak; Ludmila Borodulin-Nadzieja; Lech Polonski; Waldemar Banasiak; Philip A Poole-Wilson; Stefan D Anker; Piotr Ponikowski
Circulating estradiol and mortality in men with systolic chronic heart failure.
JAMA : the journal of the American Medical Association 2009;301(18):1892-901.
2009: Wayne C Levy; Dariush Mozaffarian; David T Linker; Kenneth W Kenyon; John G F Cleland; Michel Komajda; Willem J Remme; Christian Torp-Pedersen; Marco Metra; Philip A Poole-Wilson
Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials.
European journal of heart failure 2009;11(3):256-63.
2009: Ewa Jankowska; Justyna Jakubaszko; Aldona Cwynar; Jacek Majda; Beata Ponikowska; Dorota Kustrzycka-Kratochwil; Krzysztof Reczuch; Ludmila Borodulin-Nadzieja; Waldemar Banasiak; Philip A Poole-Wilson; Piotr Ponikowski
Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants.
European journal of heart failure 2009;11(1):28-38.
2008: Philip A Poole-Wilson
Global differences in the outcome of heart failure: implications for clinical practice.
Journal of the American College of Cardiology 2008;52(20):1649-51.
2008: Benjamin A Steinberg; Deepak L Bhatt; Shamir Mehta; Philip A Poole-Wilson; Philip O'Hagan; Gilles Montalescot; Christie M Ballantyne; Christopher P Cannon
Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease.
American heart journal 2008;156(4):719-27.
2008: Marvin A Konstam; Philip A Poole-Wilson; Kenneth Dickstein; Helmut Drexler; Steven J Justice; Michel Komajda; William Malbecq; Felipe A Martinez; James D Neaton; Gunter A J Riegger; Soneil Guptha
Design of the heart failure endpoint evaluation of AII-antagonist losartan (HEAAL) study in patients intolerant to ACE-inhibitor.
European journal of heart failure 2008;10(9):899-906.
2008: Philip A Poole-Wilson; Sandeep Seth
Rheumatic fever: the potential advantages of technology.
Nature clinical practice. Cardiovascular medicine 2008;5(7):426-7.
2008: Ali Vazir; Peter C Hastings; Ioannis Papaioannou; Philip A Poole-Wilson; Martin R Cowie; Mary J Morrell; Anita K Simonds
Variation in severity and type of sleep-disordered breathing throughout 4 nights in patients with heart failure.
Respiratory medicine 2008;102(6):831-9.
2008: Konstantinos Dimopoulos; Gerhard-Paul Diller; Evdokia Koltsida; Antonia Pijuan-Domenech; Sofia A Papadopoulou; Sonya V Babu-Narayan; Tushar V Salukhe; Massimo F Piepoli; Philip A Poole-Wilson; Nicky Best; Darrel P Francis; Michael A Gatzoulis
Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease.
Circulation 2008;117(18):2320-8.
2008: Bridget-Anne Kirwan; Jacobus Lubsen; Sophie de Brouwer; Frederik J van Dalen; Stuart J Pocock; Tim Clayton; Nicolas Danchin; Philip A Poole-Wilson
Quality management of a large randomized double-blind multi-centre trial: the ACTION experience.
Contemporary clinical trials 2008;29(2):259-69.
2008: Gábor Földes; Stephan von Haehling; Darlington O Okonko; Ewa Jankowska; Philip A Poole-Wilson; Stefan D Anker
Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure.
International journal of cardiology 2008;124(1):80-5.
2008: Philip A Poole-Wilson
Differences in European and North American approaches to the management of heart failure.
Cardiology clinics 2008;26(1):107-12, viii.
2008: Philip A Poole-Wilson
Focus on mechanical assist devices for the treatment of heart failure.
Nature clinical practice. Cardiovascular medicine 2008;5(2):59.
2008: Darlington O Okonko; Agnieszka Grzeslo; Tomasz Witkowski; Amit K J Mandal; Robert M Slater; Michael Roughton; Gábor Földes; Thomas Thum; Jacek Majda; Waldemar Banasiak; Constantinos G Missouris; Philip A Poole-Wilson; Stefan D Anker; Piotr Ponikowski
Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
Journal of the American College of Cardiology 2008;51(2):103-12.
2008: Guiqing Yao; Nick Freemantle; Marcus Flather; Puvan Tharmanathan; Andrew Coats; Philip A Poole-Wilson
Long-term cost-effectiveness analysis of nebivolol compared with standard care in elderly patients with heart failure: an individual patient-based simulation model.
PharmacoEconomics 2008;26(10):879-89.
2008: Alexander R Lyon; Paul S C Rees; Sanjay Prasad; Philip A Poole-Wilson; Sian E Harding
Stress (Takotsubo) cardiomyopathy--a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning.
Nature clinical practice. Cardiovascular medicine 2008;5(1):22-9.
2008: Richard M Lewis; David J Gordon; Philip A Poole-Wilson; Jeffrey S Borer; Faiez Zannad
Similarities and differences in design considerations for cell therapy and pharmacologic cardiovascular clinical trials.
Cardiology 2008;110(2):73-80.
2008: Tushar V Salukhe; Konstantinos Dimopoulos; Richard Sutton; Philip A Poole-Wilson; Michael Y Henein; M Morgan; Jonathan R Clague; Darrel P Francis
Instantaneous effects of resynchronisation therapy on exercise performance in heart failure patients: the mechanistic role and predictive power of total isovolumic time.
Heart (British Cardiac Society) 2008;94(1):59-64.
2007: Willem J Remme; John G F Cleland; Leif Erhardt; Phillip Spark; Christian Torp-Pedersen; Marco Metra; Michel Komajda; Christine Moullet; Mary Ann Lukas; Philip A Poole-Wilson; Andrea Di Lenarda; Karl Swedberg
Effect of carvedilol and metoprolol on the mode of death in patients with heart failure.
European journal of heart failure 2007;9(11):1128-35.
2007: Bridget-Anne Kirwan; Jacobus Lubsen; Sophie de Brouwer; Nicolas Danchin; Alexander Battler; Antoni Bayes de Luna; Peter H J M Dunselman; Stephen Glasser; Peter J Koudstaal; George Sutton; Frederik J van Dalen; Philip A Poole-Wilson
Diagnostic criteria and adjudication process both determine published event-rates: the ACTION trial experience.
Contemporary clinical trials 2007;28(6):720-9.
2007: Anja Sandek; Juergen Bauditz; Alexander Swidsinski; Sabine Buhner; Jutta Weber-Eibel; Stephan von Haehling; Wieland Schroedl; Tim Karhausen; Wolfram Doehner; Mathias Rauchhaus; Philip A Poole-Wilson; Hans-Dieter Volk; Herbert Lochs; Stefan D Anker
Altered intestinal function in patients with chronic heart failure.
Journal of the American College of Cardiology 2007;50(16):1561-9.
2007: Kshama Wechalekar; Fu Siong Ng; Philip A Poole-Wilson; Alison Duncan; christopher nutting; Vahini V Naidoo; S Richard Underwood
Cardiac amyloidosis diagnosed incidentally by bone scintigraphy.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2007;14(5):750-3.
2007: Marco Metra; Christian Torp-Pedersen; John G F Cleland; Andrea Di Lenarda; Michel Komajda; Willem J Remme; Livio Dei Cas; Phillip Spark; Karl Swedberg; Philip A Poole-Wilson
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET.
European journal of heart failure 2007;9(9):901-9.
2007: Lars G Olsson; Karl Swedberg; John G F Cleland; Phillip Spark; Michel Komajda; Marco Metra; Christian Torp-Pedersen; Willem J Remme; Armin Scherhag; Philip A Poole-Wilson
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial.
European journal of heart failure 2007;9(8):795-801.
2007: Luis M Ruilope; Bridget-Anne Kirwan; Sophie de Brouwer; Nicolas Danchin; Keith A A Fox; Gilbert Wagener; Julian Segura; Philip A Poole-Wilson; Jacobus Lubsen
Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome.
Journal of hypertension 2007;25(8):1711-8.
2007: Philip A Poole-Wilson; Zoltán Vokó; Bridget-Anne Kirwan; Sophie de Brouwer; Peter H J M Dunselman; Jacobus Lubsen
Clinical course of isolated stable angina due to coronary heart disease.
European heart journal 2007;28(16):1928-35.
2007: Anthony M Dart; Jan Erik Otterstad; Bridget-Anne Kirwan; John D Parker; Sophie de Brouwer; Philip A Poole-Wilson; Jacobus Lubsen
Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina: The ACTION study.
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2007;8(4):275-83.
2007: Christian Torp-Pedersen; Marco Metra; Andrew Charlesworth; Phillip Spark; Mary Ann Lukas; Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Willem J Remme; Armin Scherhag
Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).
Heart (British Cardiac Society) 2007;93(8):968-73.
2007: Dariush Mozaffarian; Stefan D Anker; Inder Anand; David T Linker; Mark D Sullivan; John G F Cleland; Peter E Carson; Aldo P Maggioni; Douglas L Mann; Bertram Pitt; Philip A Poole-Wilson; Wayne C Levy
Prediction of mode of death in heart failure: the Seattle Heart Failure Model.
Circulation 2007;116(4):392-8.
2007: Philip A Poole-Wilson
Patients who have dilated cardiomyopathy must have a trial of bridge to recovery: the case against that proposition.
Heart failure clinics 2007;3(3):317-9.
2007: Daniela Dobre; Dirk J van Veldhuisen; Giacomo Mordenti; Marius Vintila; Flora M Haaijer-Ruskamp; Andrew J S Coats; Philip A Poole-Wilson; Marcus Flather
Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial.
American heart journal 2007;154(1):109-15.
2007: Philip A Poole-Wilson; Bridget-Anne Kirwan; Zoltán Vokó; Sophie de Brouwer; Peter H J M Dunselman; Frederik J van Dalen; Jacobus Lubsen
Resource utilization implications of treatment were able to be assessed from appropriately reported clinical trial data.
Journal of clinical epidemiology 2007;60(7):727-33.
2007: Jacobus Lubsen; Zoltán Vokó; Philip A Poole-Wilson; Bridget-Anne Kirwan; Sophie de Brouwer
Blood pressure reduction in stable angina by nifedipine was related to stroke and heart failure reduction but not to coronary interventions.
Journal of clinical epidemiology 2007;60(7):720-6.
2007: Benjamin A Steinberg; Christie M Ballantyne; Deepak L Bhatt; Gilles Montalescot; Shamir Mehta; Philip O'Hagan; Philip A Poole-Wilson; Christopher P Cannon
An annual, prospective, international study of outpatients with cardiovascular disease or risk factors: design and methods of the CardioMonitor registry.
Critical pathways in cardiology 2007;6(2):72-5.
2007: Christian Torp-Pedersen; Marco Metra; Phillip Spark; Mary Ann Lukas; Christine Moullet; Armin Scherhag; Michel Komajda; John G F Cleland; Willem J Remme; Andrea Di Lenarda; Karl Swedberg; Philip A Poole-Wilson
The safety of amiodarone in patients with heart failure.
Journal of cardiac failure 2007;13(5):340-5.
2007: Philip A Poole-Wilson
Millennium development goals: an unbalanced approach to global health.
Nature clinical practice. Cardiovascular medicine 2007;4(6):289.
2007: Fernando A Botoni; Philip A Poole-Wilson; Antonio Ribeiro; Darlington O Okonko; Bráulio M R Oliveira; Airandes S Pinto; Mauro Teixeira; Antonio Lucio Teixeira; Adelina M Reis; Jackellyne B P Dantas; Cid S Ferreira; wilson tavares; Manoel O C Rocha
A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy.
American heart journal 2007;153(4):544.e1-8.
2007: Willem J Remme; Christian Torp-Pedersen; John G F Cleland; Philip A Poole-Wilson; Marco Metra; Michel Komajda; Karl Swedberg; Andrea Di Lenarda; Phillip Spark; Armin Scherhag; Christine Moullet; Mary Ann Lukas
Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.
Journal of the American College of Cardiology 2007;49(9):963-71.
2007: Javier Escaned; Lars Rydén; José Luis Zamorano; Philip A Poole-Wilson; Valentín Fuster; Anselm Gitt; Francisco Fernández-Avilés; Wilma J M Scholte op Reimer; Eduardo de Teresa; Luis Alonso-Pulpón; Michal Tendera
[Trends and contexts in European cardiology practice for the next 15 years. The Madrid Declaration: a report from the European Conference on the Future of Cardiology, Madrid, 2-3 June 2006].
Revista española de cardiología 2007;60(3):294-8.
2007: Javier Escaned; Lars Rydén; José Luis Zamorano; Philip A Poole-Wilson; Valentin Fuster; Anselm Gitt; Francisco Fernández-Avilés; Wilma J M Scholte op Reimer; Eduardo de Teresa; Luis Alonso-Pulpón; Michal Tendera
Trends and contexts in European cardiology practice for the next 15 years: the Madrid Declaration: a report from the European Conference on the Future of Cardiology, Madrid, 2-3 June 2006.
European heart journal 2007;28(5):634-7.
2007: George C Sutton; Jan Erik Otterstad; Bridget-Anne Kirwan; Zoltán Vokó; Sophie de Brouwer; Jacobus Lubsen; Philip A Poole-Wilson
The development of heart failure in patients with stable angina pectoris.
European journal of heart failure 2007;9(3):234-42.
2007: Piotr Ponikowski; Stefan D Anker; Joanna Szachniewicz; Darlington O Okonko; Mark Ledwidge; Robert Zymlinski; Enda Ryan; Scott M Wasserman; Nigel Baker; Dylan Rosser; Stuart D Rosen; Philip A Poole-Wilson; Waldemar Banasiak; Andrew J S Coats; Ken McDonald
Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.
Journal of the American College of Cardiology 2007;49(7):753-62.
2007: Thomas Thum; Sarah Hoeber; Sabrina Froese; Ivonne Klink; Dirk O Stichtenoth; Paolo Galuppo; Marten Jakob; Dimitrios Tsikas; Stefan D Anker; Philip A Poole-Wilson; Jürgen Borlak; Georg Ertl; Johann Bauersachs
Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1.
Circulation research 2007;100(3):434-43.
2007: Stephen Westaby; Philip A Poole-Wilson
Mechanical circulatory support in the UK.
BMJ (Clinical research ed.) 2007;334(7586):167-8.
2007: Philip A Poole-Wilson
Cardiovascular health in Europe: a global problem.
Journal of the American College of Cardiology 2007;49(1):117-9.
2007: Philip A Poole-Wilson
Chronic heart failure.
Timely topics in medicine. Cardiovascular diseases 2007;11():E2.
2007: Alan J Girling; Guy Freeman; Jason P Gordon; Philip A Poole-Wilson; David A Scott; Richard Lilford
Modeling payback from research into the efficacy of left-ventricular assist devices as destination therapy.
International journal of technology assessment in health care 2007;23(2):269-77.
2007: Michael Motro; Bridget-Anne Kirwan; Sophie de Brouwer; Philip A Poole-Wilson; Joseph Shemesh
Tracking coronary calcification and atherosclerotic lesions in patients with stable angina pectoris undergoing nifedipine therapy.
Cardiology 2007;107(3):165-71.
2006: Jacobus Lubsen; Philip A Poole-Wilson
The DREAM trial.
Lancet 2006;368(9552):2050; author reply 2050-1.
2006: Ravi G Assomull; Sanjay K Prasad; Jonathan Lyne; Gillian Smith; Elizabeth D Burman; Mohammed Khan; Mary N Sheppard; Philip A Poole-Wilson; Dudley J Pennell
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.
Journal of the American College of Cardiology 2006;48(10):1977-85.
2006: Ewa Jankowska; Bartosz Biel; Jacek Majda; Alicja Szklarska; Monika Lopuszanska; Marek Medras; Stefan D Anker; Waldemar Banasiak; Philip A Poole-Wilson; Piotr Ponikowski
Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival.
Circulation 2006;114(17):1829-37.
2006: Philip A Poole-Wilson; Stuart J Pocock; Keith A A Fox; Robert A Henderson; D J Wheatley; Douglas A Chamberlain; T R D Shaw; Tim C Clayton
Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial.
Heart (British Cardiac Society) 2006;92(10):1473-9.
2006: Stefan D Anker; Andrew L Clark; Ralph Winkler; Christian Zugck; Mariantonietta Cicoira; Piotr Ponikowski; Constantinos H Davos; Waldemar Banasiak; Piero Zardini; Markus Haass; Jochen Senges; Andrew J S Coats; Philip A Poole-Wilson; Bertram Pitt
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients.
International journal of cardiology 2006;112(2):234-42.
2006: Gerhard-Paul Diller; Konstantinos Dimopoulos; Darlington O Okonko; Anselm Uebing; Craig S Broberg; Sonya V Babu-Narayan; Stephanie Bayne; Philip A Poole-Wilson; Richard Sutton; Darrel P Francis; Michael A Gatzoulis
Heart rate response during exercise predicts survival in adults with congenital heart disease.
Journal of the American College of Cardiology 2006;48(6):1250-6.
2006: Philip A Poole-Wilson; Alexander R Lyon; Adam M Jacques
A commentary on clinical trials in chronic heart failure.
Seminars in cardiothoracic and vascular anesthesia 2006;10(3):242-5.
2006: Konstantinos Dimopoulos; Darlington O Okonko; Gerhard-Paul Diller; Craig S Broberg; Tushar V Salukhe; Sonya V Babu-Narayan; Wei Li; Anselm Uebing; Stephanie Bayne; Roland Wensel; Massimo F Piepoli; Philip A Poole-Wilson; Darrel P Francis; Michael A Gatzoulis
Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival.
Circulation 2006;113(24):2796-802.
2006: Jan Erik Otterstad; Bridget-Anne Kirwan; Jacobus Lubsen; Sophie de Brouwer; Keith A A Fox; Pernille Corell; Philip A Poole-Wilson
Incidence and outcome of atrial fibrillation in stable symptomatic coronary disease.
Scandinavian cardiovascular journal : SCJ 2006;40(3):152-9.
2006: Michel Komajda; Stefan D Anker; Andrew Charlesworth; Darlington O Okonko; Marco Metra; Andrea Di Lenarda; Willem J Remme; Christine Moullet; Karl Swedberg; John G F Cleland; Philip A Poole-Wilson
The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.
European heart journal 2006;27(12):1440-6.
2006: Ewa Jankowska; Piotr Ponikowski; Massimo F Piepoli; Waldemar Banasiak; Stefan D Anker; Philip A Poole-Wilson
Autonomic imbalance and immune activation in chronic heart failure - pathophysiological links.
Cardiovascular research 2006;70(3):434-45.
2006: Inger Ekman; Gull Andersson; Kurt Boman; Andrew Charlesworth; John G F Cleland; Philip A Poole-Wilson; Karl Swedberg
Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trial.
Patient education and counseling 2006;61(3):348-53.
2006: Tushar V Salukhe; Darrel P Francis; Michelle Morgan; Jonathan R Clague; Richard Sutton; Philip A Poole-Wilson; Michael Y Henein
Mechanism of cardiac output gain from cardiac resynchronization therapy in patients with coronary artery disease or idiopathic dilated cardiomyopathy.
The American journal of cardiology 2006;97(9):1358-64.
2006: Martin D Thomas; Kevin F Fox; David A Wood; J Simon R Gibbs; A J S Coats; Michael Y Henein; Philip A Poole-Wilson; George C Sutton
Echocardiographic features and brain natriuretic peptides in patients presenting with heart failure and preserved systolic function.
Heart (British Cardiac Society) 2006;92(5):603-8.
2006: John G F Cleland; Andrew Charlesworth; Jacobus Lubsen; Karl Swedberg; Willem J Remme; Leif Erhardt; Andrea Di Lenarda; Michel Komajda; Marco Metra; Christian Torp-Pedersen; Philip A Poole-Wilson
A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET).
Journal of the American College of Cardiology 2006;47(8):1603-11.
2006: Wayne C Levy; Dariush Mozaffarian; David T Linker; Santosh C Sutradhar; Stefan D Anker; Anne B Cropp; Inder Anand; Aldo Maggioni; Paul Burton; Mark D Sullivan; Bertram Pitt; Philip A Poole-Wilson; Douglas L Mann; Milton Packer
The Seattle Heart Failure Model: prediction of survival in heart failure.
Circulation 2006;113(11):1424-33.
2006: Stefano Ghio; Giulia Magrini; Alessandra Serio; Catherine Klersy; Alessandro Fucili; Alessandro Fucilli; Aleksandr Ronaszèki; Pal Karpati; Giacomo Mordenti; Angela Capriati; Philip A Poole-Wilson; Luigi Tavazzi
Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy.
European heart journal 2006;27(5):562-8.
2006: Philip A Poole-Wilson; Bridget-Anne Kirwan; Zoltán Vokó; Sophie de Brouwer; Frederik J van Dalen; Jacobus Lubsen
Safety of nifedipine GITS in stable angina: the ACTION trial.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2006;20(1):45-54.
2005: Thomas Thum; Johann Bauersachs; Philip A Poole-Wilson; Hans-Dieter Volk; Stefan D Anker
The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle.
Journal of the American College of Cardiology 2005;46(10):1799-802.
2005: Thomas Thum; Dimitrios Tsikas; Sylvia Stein; Maximilian Schultheiss; Martin Eigenthaler; Stefan D Anker; Philip A Poole-Wilson; Georg Ertl; Johann Bauersachs
Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.
Journal of the American College of Cardiology 2005;46(9):1693-701.
2005: Darlington O Okonko; Dirk J van Veldhuisen; Philip A Poole-Wilson; Stefan D Anker
Anaemia of chronic disease in chronic heart failure: the emerging evidence.
European heart journal 2005;26(21):2213-4.
2005: Marco Metra; Christian Torp-Pedersen; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Michel Komajda; Willem J Remme; Beatrix Lutiger; Armin Scherhag; Mary Ann Lukas; Andrew Charlesworth; Philip A Poole-Wilson
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial.
European heart journal 2005;26(21):2259-68.
2005: Tim C Clayton; Jacobus Lubsen; Stuart J Pocock; Zoltán Vokó; Bridget-Anne Kirwan; Keith A A Fox; Philip A Poole-Wilson
Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients.
BMJ (Clinical research ed.) 2005;331(7521):869.
2005: Keith A A Fox; Philip A Poole-Wilson; Tim C Clayton; RA Henderson; T R D Shaw; D J Wheatley; Richard Knight; Stuart J Pocock
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial.
Lancet 2005;366(9489):914-20.
2005: Gerhard-Paul Diller; Konstantinos Dimopoulos; Darlington O Okonko; Wei Li; Sonya V Babu-Narayan; Craig S Broberg; Bengt Johansson; Beatriz Bouzas; Michael J Mullen; Philip A Poole-Wilson; Darrel P Francis; Michael A Gatzoulis
Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication.
Circulation 2005;112(6):828-35.
2005: Rakesh Sharma; Aidan P Bolger; Mathias Rauchhaus; Stephan von Haehling; Wolfram Doehner; Ian M Adcock; Peter J Barnes; Philip A Poole-Wilson; Hans-Dieter Volk; Andrew J S Coats; Sam Lim; Stefan D Anker
Cellular endotoxin desensitization in patients with severe chronic heart failure.
European journal of heart failure 2005;7(5):865-8.
2005: Michel Komajda; Pablo Lapuerta; Nancy Hermans; José Ramon Gonzalez-Juanatey; Dirk J van Veldhuisen; Erland Erdmann; Luigi Tavazzi; Philip A Poole-Wilson; Claude Le Pen
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey.
European heart journal 2005;26(16):1653-9.
2005: Philip A Poole-Wilson
The prevention of cardiovascular disease worldwide: whose task and WHO's task?
Clinical medicine (London, England) 2005;5(4):379-84.
2005: Marvin A Konstam; James D Neaton; Philip A Poole-Wilson; Bertram Pitt; Robert Segal; Divakar Sharma; Erik J Dasbach; George W Carides; Kenneth Dickstein; Günter A J Riegger; A John Camm; Alfonso Martinez; Deborah C Bradstreet; Leila S Ikeda; Emanuela P Santoro
Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II).
American heart journal 2005;150(1):123-31.
2005: Darlington O Okonko; Martino Crosato; Paul R Kalra; Mariantonietta Cicoira; Matthias John; Wolfram Doehner; Andrew J S Coats; Philip A Poole-Wilson; Stefan D Anker
Association of deranged adrenal steroid metabolism with anemia in chronic heart failure.
The American journal of cardiology 2005;96(1):101-3.
2005: Karl Swedberg; Lars G Olsson; Andrew Charlesworth; John G F Cleland; Peter Hanrath; Michel Komajda; Marco Metra; Christian Torp-Pedersen; Philip A Poole-Wilson
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.
European heart journal 2005;26(13):1303-8.
2005: Andrea Di Lenarda; Willem J Remme; Andrew Charlesworth; John G F Cleland; Beatrix Lutiger; Marco Metra; Michel Komajda; Christian Torp-Pedersen; Armin Scherhag; Karl Swedberg; Philip A Poole-Wilson
Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
European journal of heart failure 2005;7(4):640-9.
2005: Rakesh Sharma; Stephan von Haehling; Mathias Rauchhaus; Aidan P Bolger; Sabine Genth-Zotz; Wolfram Doehner; Brian Oliver; Philip A Poole-Wilson; Hans-Dieter Volk; Andrew J S Coats; Ian M Adcock; Stefan D Anker
Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins.
European journal of heart failure 2005;7(4):479-84.
2005: Inger Ekman; John G F Cleland; Karl Swedberg; Andrew Charlesworth; Marco Metra; Philip A Poole-Wilson
Symptoms in patients with heart failure are prognostic predictors: insights from COMET.
Journal of cardiac failure 2005;11(4):288-92.
2005: Michael P Siegenthaler; Stephen Westaby; O Howard Frazier; Jürgen Martin; Adrian Banning; Desiree Robson; John Pepper; Philip A Poole-Wilson; Friedhelm Beyersdorf
Advanced heart failure: feasibility study of long-term continuous axial flow pump support.
European heart journal 2005;26(10):1031-8.
2005: Tushar V Salukhe; Darrel P Francis; Jonathan R Clague; Richard Sutton; Philip A Poole-Wilson; Michael Y Henein
Chronic heart failure patients with restrictive LV filling pattern have significantly less benefit from cardiac resynchronization therapy than patients with late LV filling pattern.
International journal of cardiology 2005;100(1):5-12.
2005: Stephan von Haehling; Sabine Genth-Zotz; Aidan P Bolger; Paul R Kalra; Michael Kemp; Ian M Adcock; Philip A Poole-Wilson; Rainer Dietz; Stefan D Anker
Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chronic heart failure and the role of beta-adrenergic receptors.
The American journal of cardiology 2005;95(7):885-9.
2005: Federica de Giuli; Kay-Tee Khaw; Martin R Cowie; George C Sutton; Roberto Ferrari; Philip A Poole-Wilson
Incidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom.
European journal of heart failure 2005;7(3):295-302.
2005: Jacobus Lubsen; Gilbert Wagener; Bridget-Anne Kirwan; Sophie de Brouwer; Philip A Poole-Wilson
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial.
Journal of hypertension 2005;23(3):641-8.
2005: Bridget-Anne Kirwan; Jacobus Lubsen; Philip A Poole-Wilson
Treatment of angina pectoris: associations with symptom severity.
International journal of cardiology 2005;98(2):299-306.
2005: Christian Torp-Pedersen; Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Beatrix Lutiger; Marco Metra; Willem J Remme; Armin Scherhag; Allan Skene
Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
American heart journal 2005;149(2):370-6.
2005: Marcus Flather; Marcelo C Shibata; Andrew J S Coats; Dirk J van Veldhuisen; Aleksandr Parkhomenko; Joszef Borbola; Alain Cohen-Solal; Dan Dumitrascu; Roberto Ferrari; Philippe Lechat; Jordi Soler-Soler; Luigi Tavazzi; Lenka Spinarova; Jirí Toman; Michael Böhm; Stefan D Anker; Simon G Thompson; Philip A Poole-Wilson
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
European heart journal 2005;26(3):215-25.
2005: Alicia M Maceira; Jayshree Joshi; Sanjay K Prasad; James Moon; Enrica Perugini; Idris Harding; Mary N Sheppard; Philip A Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Cardiovascular magnetic resonance in cardiac amyloidosis.
Circulation 2005;111(2):186-93.
2005: Enrica Perugini; Claudio Rapezzi; Letizia Bacchi Reggiani; Philip A Poole-Wilson; Angelo Branzi; Michael Y Henein
Comparison of ventricular long-axis function in patients with cardiac amyloidosis versus idiopathic restrictive cardiomyopathy.
The American journal of cardiology 2005;95(1):146-9.
2004: Nadire N Ali; X Xu; Marta Brito-Martins; Philip A Poole-Wilson; Sian E Harding; Stephen J Fuller
Beta-adrenoceptor subtype dependence of chronotropy in mouse embryonic stem cell-derived cardiomyocytes.
Basic research in cardiology 2004;99(6):382-91.
2004: Michael Oliver; Philip A Poole-Wilson; James Shephered; Mattij Tikkanen
Lower patient's cholesterol now. Trial evidence shows clear benefits from secondary prevention. 1995.
Atherosclerosis. Supplements 2004;5(3):89-90.
2004: Mariantonietta Cicoira; Constantinos H Davos; Darrel P Francis; Wolfram Doehner; Luisa Zanolla; Lorenzo Franceschini; Massimo F Piepoli; Andrew J S Coats; Piero Zardini; Philip A Poole-Wilson; Stefan D Anker
Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue.
Journal of cardiac failure 2004;10(5):421-6.
2004: Philip A Poole-Wilson; Jacobus Lubsen; Bridget-Anne Kirwan; Frederik J van Dalen; Gilbert Wagener; Nicolas Danchin; Hanjörg Just; Keith A A Fox; Stuart J Pocock; Tim C Clayton; Michael Motro; John D Parker; Martial G Bourassa; Anthony M Dart; Per Hildebrandt; Ake Hjalmarson; Johannes A Kragten; G Peter Molhoek; Jan Erik Otterstad; Ricardo Seabra-Gomes; Jordi Soler-Soler; Simon Weber
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial.
Lancet 2004;364(9437):849-57.
2004: Tim C Clayton; Stuart J Pocock; Robert A Henderson; Philip A Poole-Wilson; T R D Shaw; R Knight; Keith A A Fox
Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial.
European heart journal 2004;25(18):1641-50.
2004: James Moon; Diego Perez de Arenaza; Andrew G Elkington; Anil K Taneja; Anna S John; Duolao Wang; Rajesh Janardhanan; Roxy Senior; Avijit Lahiri; Philip A Poole-Wilson; Dudley J Pennell
The pathologic basis of Q-wave and non-Q-wave myocardial infarction: a cardiovascular magnetic resonance study.
Journal of the American College of Cardiology 2004;44(3):554-60.
2004: Rakesh Sharma; Darrel P Francis; Bertram Pitt; Philip A Poole-Wilson; Andrew J S Coats; Stefan D Anker
Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial.
European heart journal 2004;25(12):1021-8.
2004: Philip A Poole-Wilson
Commentary on the Carvedilol or Metoprolol European Trial (COMET).
The American journal of cardiology 2004;93(9A):40B-2B.
2004: Rüdiger von Harsdorf; Philip A Poole-Wilson; Rainer Dietz
Regenerative capacity of the myocardium: implications for treatment of heart failure.
Lancet 2004;363(9417):1306-13.
2004: Marco Metra; Livio Dei Cas; Andrea Di Lenarda; Philip A Poole-Wilson
Beta-blockers in heart failure: are pharmacological differences clinically important?
Heart failure reviews 2004;9(2):123-30.
2004: John G F Cleland; Kevin Goode; Leif Erhardt; Willem J Remme; Andrew Charlesworth; Philip A Poole-Wilson; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Marco Metra; Karl Swedberg; Christian Torp-Pedersen
A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET).
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(2):139-52.
2004: Paresh A Mehta; S McDonagh; Philip A Poole-Wilson; Richard Grocott-Mason; Simon W Dubrey
Heart failure in a district general hospital: are target doses of beta-blockers realistic?
QJM : monthly journal of the Association of Physicians 2004;97(3):133-9.
2003: Antoni Bayés de Luna; Tak-Fu Tse; Marianne Burle de Figueiredo; Mario Maranhão; Janet Voûte; Sania Nishtar; Valentin Fuster; Philip A Poole-Wilson
World Heart Day: a World Heart Federation enterprise promoting the prevention of heart disease and stroke across the world.
Circulation 2003;108(9):1038-40.
2003: Paul R Kalra; Timothy Collier; Martin R Cowie; Kevin F Fox; David A Wood; Philip A Poole-Wilson; Andrew J S Coats; George C Sutton
Haemoglobin concentration and prognosis in new cases of heart failure.
Lancet 2003;362(9379):211-2.
2003: Rakesh Sharma; Aidan P Bolger; Wei Li; Periklis A Davlouros; Hans-Dieter Volk; Philip A Poole-Wilson; Andrew J S Coats; Michael A Gatzoulis; Stefan D Anker
Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease.
The American journal of cardiology 2003;92(2):188-93.
2003: Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Jacobus Lubsen; Beatrix Lutiger; Marco Metra; Willem J Remme; Christian Torp-Pedersen; Armin Scherhag; Allan Skene
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.
Lancet 2003;362(9377):7-13.
2003: J Sanford Schwartz; Y Richard Wang; John G F Cleland; Longlong Gao; Mark Weiner; Philip A Poole-Wilson
High- versus low-dose angiotensin converting enzyme inhibitor therapy in the treatment of heart failure: an economic analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial.
The American journal of managed care 2003;9(6):417-24.
2003: Philip A Poole-Wilson; Shu-Ren Xue
New therapies for the management of acute heart failure.
Current cardiology reports 2003;5(3):229-36.
2003: Paul R Kalra; Aidan P Bolger; Darrel P Francis; Sabine Genth-Zotz; Rakesh Sharma; Piotr Ponikowski; Philip A Poole-Wilson; Andrew J S Coats; Stefan D Anker
Effect of anemia on exercise tolerance in chronic heart failure in men.
The American journal of cardiology 2003;91(7):888-91.
2003: M Mahmoudi; S McDonagh; Philip A Poole-Wilson; Simon W Dubrey
Obstacles to the initiation of beta blockers for heart failure in a specialised clinic within a district general hospital.
Heart (British Cardiac Society) 2003;89(4):442-4.
2003: Mark Scoote; Philip A Poole-Wilson; Alan J Williams
The therapeutic potential of new insights into myocardial excitation-contraction coupling.
Heart (British Cardiac Society) 2003;89(4):371-6.
2003: Stefan D Anker; Abdissa Negassa; Andrew J S Coats; Rizwan Afzal; Philip A Poole-Wilson; Jay N Cohn; Salim Yusuf
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.
Lancet 2003;361(9363):1077-83.
2003: Philip A Poole-Wilson
ACE inhibitors and ARBs in chronic heart failure: the established, the expected, and the pragmatic.
The Medical clinics of North America 2003;87(2):373-89.
2003: Paul R Kalra; Jonathon R Clague; Aidan P Bolger; Stefan D Anker; Philip A Poole-Wilson; Allan D Struthers; Andrew J Coats
Myocardial production of C-type natriuretic peptide in chronic heart failure.
Circulation 2003;107(4):571-3.
2003: Yi Gang; Takuya Ono; Katerina Hnatkova; Kenich Hashimoto; A John Camm; Bertram Pitt; Philip A Poole-Wilson; Marek Malik
QT dispersion has no prognostic value in patients with symptomatic heart failure: an ELITE II substudy.
Pacing and clinical electrophysiology : PACE 2003;26(1 Pt 2):394-400.
2003: Philip A Poole-Wilson; B F Uretsky; K Thygesen; John G F Cleland; Barrie Massie; L Rydén
Mode of death in heart failure: findings from the ATLAS trial.
Heart (British Cardiac Society) 2003;89(1):42-8.
2002: Philip A Poole-Wilson; Arnold M Katz
Future strategies of reverse remodeling: summation.
Journal of cardiac failure 2002;8(6 Suppl):S556-61.
2002: Marcelo C Shibata; Marcus Flather; Michael Böhm; Josef Borbola; Alain Cohen-Solal; Daniel Dumitrascu; Roberto Ferrari; Philippe Lechat; Alexander Parkhomenko; Jordi Soler-Soler; Luigi Tavazzi; Jirí Toman; Dirk J van Veldhuisen; Andrew J S Coats; Philip A Poole-Wilson
Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design.
International journal of cardiology 2002;86(1):77-85.
2002: Keith A A Fox; Philip A Poole-Wilson; RA Henderson; Tim C Clayton; Douglas A Chamberlain; T R D Shaw; D J Wheatley; Stuart J Pocock
Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina.
Lancet 2002;360(9335):743-51.
2002: Viorel G Florea; Michael Y Henein; Mathias Rauchhaus; Veronika Koloczek; Rakesh Sharma; Wolfram Doehner; Philip A Poole-Wilson; Andrew J S Coats; Stefan D Anker
The cardiac component of cardiac cachexia.
American heart journal 2002;144(1):45-50.
2002: Philip A Poole-Wilson; Jacobus Lubsen
Losartan for cardiovascular disease in patients with and without diabetes in the LIFE study.
Lancet 2002;359(9324):2199; author reply 2203-4.
2002: Stephen Westaby; Adrian P Banning; Satoshi Saito; David Pigott; Xu Yu Jin; Pedro A Catarino; Desiree Robson; Narain Moorjani; Attila Kardos; Philip A Poole-Wilson; Robert Jarvik; O Howard Frazier
Circulatory support for long-term treatment of heart failure: experience with an intraventricular continuous flow pump.
Circulation 2002;105(22):2588-91.
2002: Martin R Cowie; Kevin F Fox; David A Wood; C Metcalfe; Simon G Thompson; A J S Coats; Philip A Poole-Wilson; George C Sutton
Hospitalization of patients with heart failure: a population-based study.
European heart journal 2002;23(11):877-85.
2002: Philip A Poole-Wilson; John G F Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Marco Metra; Willem J Remme; Karl Swedberg; Christian Torp-Pedersen
Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET.
European journal of heart failure 2002;4(3):321-9.
2002: Philip A Poole-Wilson
NICE: guessing is not guidance. National Institute for Clinical Excellence.
Heart (British Cardiac Society) 2002;87(6):510-2.
2002: K H Darasz; S Richard Underwood; J Bayliss; SM Forbat; J Keegan; Philip A Poole-Wilson; George C Sutton; Dudley J Pennell
Measurement of left ventricular volume after anterior myocardial infarction: comparison of magnetic resonance imaging, echocardiography, and radionuclide ventriculography.
The international journal of cardiovascular imaging 2002;18(2):135-42.
2002: Philip A Poole-Wilson
Treatment of acute heart failure: out with the old, in with the new.
JAMA : the journal of the American Medical Association 2002;287(12):1578-80.
2002: RF Faris; Marcus Flather; Henry Purcell; Michael Henein; Philip A Poole-Wilson; Andrew J S Coats
Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials.
International journal of cardiology 2002;82(2):149-58.
2001: Philip A Poole-Wilson
Implications of recent heart failure trials for patients with hypertension.
Current cardiology reports 2001;3(6):504-10.
2001: Stefan D Anker; M Volterrani; CD Pflaum; Christian J Strasburger; K J Osterziel; Wolfram Doehner; M B Ranke; Philip A Poole-Wilson; A Giustina; Rainer Dietz; Andrew J S Coats
Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone.
Journal of the American College of Cardiology 2001;38(2):443-52.
2001: Piotr Ponikowski; Darrel P Francis; Massimo F Piepoli; Ceri Davies; TP Chua; Constantinos H Davos; Viorel G Florea; Waldemar Banasiak; Philip A Poole-Wilson; Andrew J S Coats; Stefan D Anker
Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis.
Circulation 2001;103(7):967-72.
2001: Kevin F Fox; Martin R Cowie; David A Wood; Andrew J S Coats; J Simon R Gibbs; S Richard Underwood; Rebecca Turner; Philip A Poole-Wilson; S W Davies; George C Sutton
Coronary artery disease as the cause of incident heart failure in the population.
European heart journal 2001;22(3):228-36.
2000: Kevin F Fox; Martin R Cowie; David A Wood; Andrew J S Coats; Philip A Poole-Wilson; George C Sutton
A Rapid Access Heart Failure Clinic provides a prompt diagnosis and appropriate management of new heart failure presenting in the community.
European journal of heart failure 2000;2(4):423-9.
2000: Stephen Westaby; A P Banning; Robert Jarvik; O Howard Frazier; David Pigott; Xu Yu Jin; Pedro A Catarino; Satoshi Saito; Desiree Robson; A Freeland; Timothy J Myers; Philip A Poole-Wilson
First permanent implant of the Jarvik 2000 Heart.
Lancet 2000;356(9233):900-3.
2000: Rakesh Sharma; Mathias Rauchhaus; Piotr Ponikowski; S Varney; Philip A Poole-Wilson; D L Mann; Andrew J S Coats; Stefan D Anker
The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
Journal of the American College of Cardiology 2000;36(2):523-8.
2000: Bertram Pitt; Philip A Poole-Wilson; Robert Segal; Alfonso Martinez; Kenneth Dickstein; A John Camm; Marvin A Konstam; Günter A J Riegger; G H Klinger; James D Neaton; Divakar Sharma; B Thiyagarajan
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.
Lancet 2000;355(9215):1582-7.
2000: Martin R Cowie; David A Wood; Andrew J S Coats; Simon G Thompson; V Suresh; Philip A Poole-Wilson; George C Sutton
Survival of patients with a new diagnosis of heart failure: a population based study.
Heart (British Cardiac Society) 2000;83(5):505-10.
2000: P D Bourdillon; Philip A Poole-Wilson
Commentary on "Effects of ischaemia and reperfusion on calcium exchange and mechanical function in isolated rabbit myocardium".
Cardiovascular research 2000;45(1):95-9.
2000: Francisco Leyva; Mathias Rauchhaus; Stefan D Anker; Anthony J Proudler; Ian F Godsland; P Stiefel; Andrew J S Coats; Philip A Poole-Wilson; John Stevenson
Non-invasive assessment of vascular function; paradoxical vascular response to intravenous glucose in coronary heart disease.
European heart journal 2000;21(1):39-44.
1999: Piotr Ponikowski; Stefan D Anker; TP Chua; D Francis; Waldemar Banasiak; Philip A Poole-Wilson; Andrew J S Coats; Massimo Piepoli
Oscillatory breathing patterns during wakefulness in patients with chronic heart failure: clinical implications and role of augmented peripheral chemosensitivity.
Circulation 1999;100(24):2418-24.
1999: Stuart A Cook; Philip A Poole-Wilson
Cardiac myocyte apoptosis.
European heart journal 1999;20(22):1619-29.
1999: Bertram Pitt; Philip A Poole-Wilson; Robert Segal; Alfonso Martinez; Kenneth Dickstein; A John Camm; Marvin A Konstam; Günter A J Riegger; G H Klinger; James D Neaton; Divakar Sharma; B Thiyagarajan
Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II.
Journal of cardiac failure 1999;5(2):146-54.
1999: Josef Niebauer; Hans-Dieter Volk; Michael Kemp; M Dominguez; R R Schumann; Mathias Rauchhaus; Philip A Poole-Wilson; Andrew J S Coats; Stefan D Anker
Endotoxin and immune activation in chronic heart failure: a prospective cohort study.
Lancet 1999;353(9167):1838-42.
1999: Stefan D Anker; Piotr Ponikowski; Andrew L Clark; Francisco Leyva; Mathias Rauchhaus; Michael Kemp; Mauro Teixeira; PG Hellewell; J Hooper; Philip A Poole-Wilson; Andrew J S Coats
Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.
European heart journal 1999;20(9):683-93.
1999: Martin R Cowie; David A Wood; Andrew J S Coats; Simon G Thompson; Philip A Poole-Wilson; V Suresh; George C Sutton
Incidence and aetiology of heart failure; a population-based study.
European heart journal 1999;20(6):421-8.
1999: Kevin F Fox; Martin R Cowie; David A Wood; Andrew J S Coats; Philip A Poole-Wilson; George C Sutton
New perspectives on heart failure due to myocardial ischaemia.
European heart journal 1999;20(4):256-62.
1998: Sian E Harding; CH Davies; A M Money-Kyrle; Philip A Poole-Wilson
An inhibitor of nitric oxide synthase does not increase contraction or beta-adrenoceptor sensitivity of ventricular myocytes from failing human heart.
Cardiovascular research 1998;40(3):523-9.
1998: Francisco Leyva; Stefan D Anker; Ian F Godsland; M Teixeira; PG Hellewell; WJ Kox; Philip A Poole-Wilson; Andrew J S Coats
Uric acid in chronic heart failure: a marker of chronic inflammation.
European heart journal 1998;19(12):1814-22.
1998: Sian E Harding; Kerry Davia; CH Davies; Federica Del Monte; A R Money-Kyrle; Philip A Poole-Wilson
From overload to failure: what happens inside the myocyte.
Annals of medicine 1998;30 Suppl 1():14-23.
1998: Jacobus Lubsen; Philip A Poole-Wilson; Stuart J Pocock; Frederik J van Dalen; J Baumann; Bridget-Anne Kirwan; A B Parker
Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic System.
European heart journal 1998;19 Suppl I():I20-32.
1998: Josef Niebauer; CD Pflaum; Andrew L Clark; Christian J Strasburger; J Hooper; Philip A Poole-Wilson; Andrew J S Coats; Stefan D Anker
Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation.
Journal of the American College of Cardiology 1998;32(2):393-7.
1998: Martin St John Sutton; J E Otterstat; Theodore Plappert; A Parker; D Sekarski; Martin G Keane; Philip A Poole-Wilson; K Lubsen
Quantitation of left ventricular volumes and ejection fraction in post-infarction patients from biplane and single plane two-dimensional echocardiograms. A prospective longitudinal study of 371 patients.
European heart journal 1998;19(5):808-16.
1998: C Allum; C Knight; Raad H Mohiaddin; Philip A Poole-Wilson
Images in cardiovascular medicine. Use of magnetic resonance imaging to demonstrate a fistula from the aorta to the right atrium.
Circulation 1998;97(10):1024.
1998: Stefan D Anker; Maurizio Volterrani; Karl Egerer; CV Felton; WJ Kox; Philip A Poole-Wilson; Andrew J S Coats
Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure.
QJM : monthly journal of the Association of Physicians 1998;91(3):199-203.
1998: Raffi R Kaprielian; Mark G Gunning; Emmanuel Dupont; Mary N Sheppard; Stephen Rothery; R Underwood; Dudley J Pennell; Alistair Hall; John Pepper; Philip A Poole-Wilson; Nicholas J Severs
Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle.
Circulation 1998;97(7):651-60.
1998: A R Money-Kyrle; CH Davies; Hardeep K Ranu; P O'Gara; NS Kent; Philip A Poole-Wilson; Sian E Harding
The role of cAMP in the frequency-dependent changes in contraction of guinea-pig cardiomyocytes.
Cardiovascular research 1998;37(2):532-40.
1997: D Harrington; Stefan D Anker; TP Chua; Katherine M Webb-Peploe; Piotr Ponikowski; Philip A Poole-Wilson; Andrew J S Coats
Skeletal muscle function and its relation to exercise tolerance in chronic heart failure.
Journal of the American College of Cardiology 1997;30(7):1758-64.
1997: Martin R Cowie; A D Struthers; David A Wood; Andrew J S Coats; Simon G Thompson; Philip A Poole-Wilson; George C Sutton
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.
Lancet 1997;350(9088):1349-53.
1997: Raffi R Kaprielian; Emmanuel Dupont; Sassan Hafizi; Philip A Poole-Wilson; A Khaghani; Magdi H Yacoub; Nicholas J Severs
Angiotensin II receptor type 1 mRNA is upregulated in atria of patients with end-stage heart failure.
Journal of molecular and cellular cardiology 1997;29(8):2299-304.
1997: Stefan D Anker; TP Chua; Piotr Ponikowski; D Harrington; JW Swan; W J Kox; Philip A Poole-Wilson; Andrew J S Coats
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.
Circulation 1997;96(2):526-34.
1997: Stefan D Anker; Francisco Leyva; Philip A Poole-Wilson; WJ Kox; John Stevenson; Andrew J S Coats
Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure.
Heart (British Cardiac Society) 1997;78(1):39-43.
1997: D Harrington; Andrew L Clark; TP Chua; Stefan D Anker; Philip A Poole-Wilson; Andrew J S Coats
Effect of reduced muscle bulk on the ventilatory response to exercise in chronic congestive heart failure secondary to idiopathic dilated and ischemic cardiomyopathy.
The American journal of cardiology 1997;80(1):90-3.
1997: TP Chua; Piotr Ponikowski; D Harrington; Stefan D Anker; Katherine M Webb-Peploe; Andrew L Clark; Philip A Poole-Wilson; Andrew J S Coats
Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure.
Journal of the American College of Cardiology 1997;29(7):1585-90.
1997: Stefan D Anker; Karl Egerer; H D Volk; WJ Kox; Philip A Poole-Wilson; Andrew J S Coats
Elevated soluble CD14 receptors and altered cytokines in chronic heart failure.
The American journal of cardiology 1997;79(10):1426-30.
1997: Stefan D Anker; Piotr Ponikowski; S Varney; TP Chua; Andrew L Clark; Katherine M Webb-Peploe; D Harrington; W J Kox; Philip A Poole-Wilson; Andrew J S Coats
Wasting as independent risk factor for mortality in chronic heart failure.
Lancet 1997;349(9058):1050-3.
1997: Stefan D Anker; JW Swan; Maurizio Volterrani; TP Chua; Andrew L Clark; Philip A Poole-Wilson; Andrew J S Coats
The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure.
European heart journal 1997;18(2):259-69.
1997: Martin R Cowie; Arend Mosterd; David A Wood; Jaap Deckers; Philip A Poole-Wilson; George C Sutton; Diederick Grobbee
The epidemiology of heart failure.
European heart journal 1997;18(2):208-25.
1997: Philip A Poole-Wilson
Remodelling of the heart is not a proven clinical concept.
Basic research in cardiology 1997;92 Suppl 2():62-4.
1997: TP Chua; D Harrington; Piotr Ponikowski; Katherine M Webb-Peploe; Philip A Poole-Wilson; Andrew J S Coats
Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure.
Journal of the American College of Cardiology 1997;29(1):147-52.
1996: Giuseppe Rosano; N S Peters; DC Lefroy; D C Lindsay; Philip M Sarrel; P Collins; Philip A Poole-Wilson
17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X.
Journal of the American College of Cardiology 1996;28(6):1500-5.
1996: Philip A Poole-Wilson; R Ferrari
Role of skeletal muscle in the syndrome of chronic heart failure.
Journal of molecular and cellular cardiology 1996;28(11):2275-85.
1996: Andrew L Clark; Philip A Poole-Wilson; Andrew J S Coats
Exercise limitation in chronic heart failure: central role of the periphery.
Journal of the American College of Cardiology 1996;28(5):1092-102.
1996: S Kaddoura; Philip A Poole-Wilson
Endothelin-1 in heart failure: a new therapeutic target?
Lancet 1996;348(9025):418-9.
1996: D C Lindsay; C A Lovegrove; M J Dunn; J G Bennett; J R Pepper; M H Yacoub; Philip A Poole-Wilson
Histological abnormalities of muscle from limb, thorax and diaphragm in chronic heart failure.
European heart journal 1996;17(8):1239-50.
1996: S Kaddoura; D Patel; J Parameshwar; J Sparrow; A Park; J Bayliss; G C Sutton; Philip A Poole-Wilson
Objective assessment of the response to treatment of severe heart failure using a 9-minute walk test on a patient-powered treadmill.
Journal of cardiac failure 1996;2(2):133-9.
1996: DC Lefroy; T Crake; F Del Monte; Giorgio Vescovo; Luciano Dalla Libera; S Harding; Philip A Poole-Wilson
Angiotensin II and contraction of isolated myocytes from human, guinea pig, and infarcted rat hearts.
The American journal of physiology 1996;270(6 Pt 2):H2060-9.
1996: S Kaddoura; J D Firth; Kenneth R Boheler; Peter H Sugden; Philip A Poole-Wilson
Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist.
Circulation 1996;93(11):2068-79.
1996: D C Lindsay; D R Holdright; D Clarke; I S Anand; Philip A Poole-Wilson; P Collins
Endothelial control of lower limb blood flow in chronic heart failure.
Heart (British Cardiac Society) 1996;75(5):469-76.
1996: Piotr Ponikowski; Giuseppe Rosano; A A Amadi; P Collins; Andrew J S Coats; Philip A Poole-Wilson; JUAN-CARLOS KASKI
Transient autonomic dysfunction precedes ST-segment depression in patients with syndrome X.
The American journal of cardiology 1996;77(11):942-7.
1996: CH Davies; Sian E Harding; Philip A Poole-Wilson
Cellular mechanisms of contractile dysfunction in human heart failure.
European heart journal 1996;17(2):189-98.
1996: S Kaddoura; N P Curzen; Timothy W Evans; J D Firth; Philip A Poole-Wilson
Tissue expression of endothelin-1 mRNA in endotoxaemia.
Biochemical and biophysical research communications 1996;218(3):641-7.
1996: Sian E Harding; L A Brown; F del Monte; CH Davies; P O'Gara; Giorgio Vescovo; D G Wynne; Philip A Poole-Wilson
Acceleration of contraction by beta-adrenoceptor stimulation is greater in ventricular myocytes from failing than non-failing human hearts.
Basic research in cardiology 1996;91 Suppl 2():53-6.
1995: CH Davies; Kerry Davia; J G Bennett; J R Pepper; Philip A Poole-Wilson; Sian E Harding
Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure.
Circulation 1995;92(9):2540-9.
1995: K H Darasz; J Bayliss; S R Underwood; J Keegan; Philip A Poole-Wilson; G C Sutton
Left ventricular volume in thrombolysed patients with acute anterior myocardial infarction: the effect of captopril and xamoterol.
International journal of cardiology 1995;51(2):137-42.
1995: Sian E Harding; Kenneth T MacLeod; CH Davies; D G Wynne; Philip A Poole-Wilson
Abnormalities of the myocytes in ischaemic cardiomyopathy.
European heart journal 1995;16 Suppl I():74-81.
1995: F del Monte; P O'Gara; Philip A Poole-Wilson; M Yacoub; Sian E Harding
Cell geometry and contractile abnormalities of myocytes from failing human left ventricle.
Cardiovascular research 1995;30(2):281-90.
1995: P Collins; Giuseppe Rosano; Philip M Sarrel; L Ulrich; Stamatis Adamopoulos; C M Beale; J G McNeill; Philip A Poole-Wilson
17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease.
Circulation 1995;92(1):24-30.
1995: P E Glennon; Peter H Sugden; Philip A Poole-Wilson
Cellular mechanisms of cardiac hypertrophy.
British heart journal 1995;73(6):496-9.
1995: Giuseppe Rosano; P Collins; JUAN-CARLOS KASKI; D C Lindsay; Philip M Sarrel; Philip A Poole-Wilson
Syndrome X in women is associated with oestrogen deficiency.
European heart journal 1995;16(5):610-4.
1995: N Ferrara; P O'Gara; D G Wynne; L A Brown; F del Monte; Philip A Poole-Wilson; Sian E Harding
Decreased contractile responses to isoproterenol in isolated cardiac myocytes from aging guinea-pigs.
Journal of molecular and cellular cardiology 1995;27(5):1141-50.
1995: Philip A Poole-Wilson
Angiotensin-converting enzyme inhibitors and calcium antagonists after acute myocardial infarction.
The American journal of cardiology 1995;75(13):4E-9E.
1995: Andrew L Clark; Maurizio Volterrani; E Cerquetani; P Ludman; JW Swan; Philip A Poole-Wilson; Andrew J S Coats
Relationship between arterial potassium and ventilation during exercise in patients with chronic heart failure.
Journal of cardiac failure 1995;1(2):133-41.
1995: Philip A Poole-Wilson
The dimensions of human cardiac myocytes; confusion caused by methodology and pathology.
Journal of molecular and cellular cardiology 1995;27(3):863-5.
1995: Giuseppe Rosano; N S Peters; JUAN-CARLOS KASKI; S I Mavrogeni; P Collins; R S Underwood; Philip A Poole-Wilson
Abnormal uptake and washout of thallium-201 in patients with syndrome X and normal-appearing scans.
The American journal of cardiology 1995;75(5):400-2.
1995: P Yue; K Chatterjee; C Beale; Philip A Poole-Wilson; P Collins
Testosterone relaxes rabbit coronary arteries and aorta.
Circulation 1995;91(4):1154-60.
1995: SM Forbat; S Thorne; S Richard Underwood; Philip A Poole-Wilson
Images in cardiovascular medicine. Magnetic resonance phase velocity mapping in dissecting aortic aneurysm. Demonstration of a proximal intimal tear.
Circulation 1995;91(1):236-7.
1995: N S Peters; C R Green; Philip A Poole-Wilson; N J Severs
Cardiac arrhythmogenesis and the gap junction.
Journal of molecular and cellular cardiology 1995;27(1):37-44.
1994: Sian E Harding; CH Davies; D G Wynne; Philip A Poole-Wilson
Contractile function and response to agonists in myocytes from failing human heart.
European heart journal 1994;15 Suppl D():35-6.
1994: D C Lindsay; I S Anand; J G Bennett; J R Pepper; M H Yacoub; S M Rothery; N J Severs; Philip A Poole-Wilson
Ultrastructural analysis of skeletal muscle. Microvascular dimensions and basement membrane thickness in chronic heart failure.
European heart journal 1994;15(11):1470-6.
1994: Sian E Harding; L A Brown; D G Wynne; CH Davies; Philip A Poole-Wilson
Mechanisms of beta adrenoceptor desensitisation in the failing human heart.
Cardiovascular research 1994;28(10):1451-60.
1994: A J Coats; Andrew L Clark; M Piepoli; Maurizio Volterrani; Philip A Poole-Wilson
Symptoms and quality of life in heart failure: the muscle hypothesis.
British heart journal 1994;72(2 Suppl):S36-9.
1994: C Jiang; S Mochizuki; Philip A Poole-Wilson; Sian E Harding; Kenneth T MacLeod
Effect of lemakalim on action potentials, intracellular calcium, and contraction in guinea pig and human cardiac myocytes.
Cardiovascular research 1994;28(6):851-7.
1994: J Sparrow; J Parameshwar; Philip A Poole-Wilson
Assessment of functional capacity in chronic heart failure: time-limited exercise on a self-powered treadmill.
British heart journal 1994;71(4):391-4.
1994: Andrew L Clark; Philip A Poole-Wilson; Andrew J S Coats
Effects of motivation of the patient on indices of exercise capacity in chronic heart failure.
British heart journal 1994;71(2):162-5.
1993: D R Holdright; D C Lindsay; D Clarke; K Fox; Philip A Poole-Wilson; P Collins
Coronary flow reserve in patients with chest pain and normal coronary arteries.
British heart journal 1993;70(6):513-9.
1993: P F Ludman; Andrew J S Coats; P Burger; Guang-Zhong Yang; Philip A Poole-Wilson; S Richard Underwood; R S Rees
Validation of measurement of regional myocardial perfusion in humans by ultrafast x-ray computed tomography.
American journal of cardiac imaging 1993;7(4):267-79.
1993: Philip A Poole-Wilson
Relation of pathophysiologic mechanisms to outcome in heart failure.
Journal of the American College of Cardiology 1993;22(4 Suppl A):22A-29A.
1993: P F Ludman; Philip A Poole-Wilson
Myocardial perfusion in humans: what can we measure?
British heart journal 1993;70(4):307-14.
1993: F Del Monte; J R Mynett; Peter H Sugden; Philip A Poole-Wilson; Sian E Harding
Subcellular mechanism of the species difference in the contractile response of ventricular myocytes to endothelin-1.
Cardioscience 1993;4(3):185-91.
1993: N S Peters; C R Green; Philip A Poole-Wilson; N J Severs
Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts.
Circulation 1993;88(3):864-75.
1993: F del Monte; A J Kaumann; Philip A Poole-Wilson; D G Wynne; J Pepper; Sian E Harding
Coexistence of functioning beta 1- and beta 2-adrenoceptors in single myocytes from human ventricle.
Circulation 1993;88(3):854-63.
1993: A J Brady; Philip A Poole-Wilson
Circulatory failure in septic shock. Nitric oxide: too much of a good thing?
British heart journal 1993;70(2):103-5.
1993: D G Wynne; Philip A Poole-Wilson; Sian E Harding
Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors.
British journal of pharmacology 1993;109(4):1071-8.
1993: Giuseppe Rosano; Philip M Sarrel; Philip A Poole-Wilson; P Collins
Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease.
Lancet 1993;342(8864):133-6.
1993: A J Brady; John Bowen Warren; Philip A Poole-Wilson; T J Williams; Sian E Harding
Nitric oxide attenuates cardiac myocyte contraction.
The American journal of physiology 1993;265(1 Pt 2):H176-82.
1993: D R Holdright; D Clarke; Philip A Poole-Wilson; K Fox; P Collins
Endothelium dependent and independent responses in coronary artery disease measured at angioplasty.
British heart journal 1993;70(1):35-42.
1993: Philip A Poole-Wilson
Heart failure. Unfinished business--a possible role for vasodilators.
International journal of cardiology 1993;40(1):1-6.
1993: P F Ludman; Maurizio Volterrani; Andrew L Clark; Philip A Poole-Wilson; S Rees; Andrew J S Coats
Skeletal muscle blood flow in heart failure measured by ultrafast computed tomography: validation by comparison with plethysmography.
Cardiovascular research 1993;27(6):1109-15.
1993: P Collins; Giuseppe Rosano; C Jiang; D Lindsay; Philip M Sarrel; Philip A Poole-Wilson
Cardiovascular protection by oestrogen--a calcium antagonist effect?
Lancet 1993;341(8855):1264-5.
1993: P F Ludman; Andrew J S Coats; Philip A Poole-Wilson; R S Rees
Measurement accuracy of cardiac output in humans: indicator-dilution technique versus geometric analysis by ultrafast computed tomography.
Journal of the American College of Cardiology 1993;21(6):1482-9.
1993: L Corr; G Burnstock; Philip A Poole-Wilson
Effects of age and hyperlipidemia on rabbit coronary responses to neuropeptide Y and the interaction with norepinephrine.
Peptides 1993;14(2):359-64.
1993: J S Gibbs; W Sanderson; L D Smith; Andrew J S Coats; Philip A Poole-Wilson; K M Fox
Low frequency oscillations in pulmonary arterial pressure in chronic heart failure.
Cardioscience 1993;4(1):31-9.
1992: A J Brady; Philip A Poole-Wilson; Sian E Harding; John Bowen Warren
Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia.
The American journal of physiology 1992;263(6 Pt 2):H1963-6.
1992: Andrew L Clark; Philip A Poole-Wilson; Andrew J S Coats
Relation between ventilation and carbon dioxide production in patients with chronic heart failure.
Journal of the American College of Cardiology 1992;20(6):1326-32.
1992: Sian E Harding; S M Jones; Giorgio Vescovo; F Del Monte; Philip A Poole-Wilson
Reduced contractile responses to forskolin and a cyclic AMP analogue in myocytes from failing human ventricle.
European journal of pharmacology 1992;223(1):39-48.
1992: P F Ludman; M Darby; N Tomlinson; Philip A Poole-Wilson; S Rees
Cardiac flow measurement by ultrafast CT: validation of continuous and pulsatile flow.
Journal of computer assisted tomography 1992;16(5):795-803.
1992: C Jiang; Philip A Poole-Wilson; Philip M Sarrel; S Mochizuki; P Collins; Kenneth T MacLeod
Effect of 17 beta-oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes.
British journal of pharmacology 1992;106(3):739-45.
1992: D C Lindsay; C Jiang; F Brunotte; Stamatis Adamopoulos; Andrew J S Coats; B Rajagopalan; Philip A Poole-Wilson; P Collins
Impairment of endothelium dependent responses in a rat model of chronic heart failure: effects of an exercise training protocol.
Cardiovascular research 1992;26(7):694-7.
1992: J Parameshwar; M M Shackell; A Richardson; Philip A Poole-Wilson; G C Sutton
Prevalence of heart failure in three general practices in north west London.
The British journal of general practice : the journal of the Royal College of General Practitioners 1992;42(360):287-9.
1992: C Jiang; Philip M Sarrel; Philip A Poole-Wilson; P Collins
Acute effect of 17 beta-estradiol on rabbit coronary artery contractile responses to endothelin-1.
The American journal of physiology 1992;263(1 Pt 2):H271-5.
1992: Philip A Poole-Wilson; N P Buller; D C Lindsay
Blood flow and skeletal muscle in patients with heart failure.
Chest 1992;101(5 Suppl):330S-332S.
1992: Sian E Harding; S M Jones; P O'Gara; F del Monte; Giorgio Vescovo; Philip A Poole-Wilson
Isolated ventricular myocytes from failing and non-failing human heart; the relation of age and clinical status of patients to isoproterenol response.
Journal of molecular and cellular cardiology 1992;24(5):549-64.
1992: J Parameshwar; Philip A Poole-Wilson; G C Sutton
Heart failure in a district general hospital.
Journal of the Royal College of Physicians of London 1992;26(2):139-42.
1992: C W Jiang; Philip M Sarrel; D C Lindsay; Philip A Poole-Wilson; P Collins
Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro.
European journal of pharmacology 1992;211(2):163-7.
1992: J Parameshwar; J Keegan; J Sparrow; G C Sutton; Philip A Poole-Wilson
Predictors of prognosis in severe chronic heart failure.
American heart journal 1992;123(2):421-6.
1991: J S Gibbs; R Ferrari; J Keegan; C Ceconi; C Wright; Kim M Fox; Philip A Poole-Wilson
The influence of right heart catheterisation on pulmonary arterial pressure in chronic heart failure: relationship to neuroendocrinal changes.
International journal of cardiology 1991;33(3):365-76.
1991: C W Jiang; Philip M Sarrel; D C Lindsay; Philip A Poole-Wilson; P Collins
Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro.
British journal of pharmacology 1991;104(4):1033-7.
1991: Philip A Poole-Wilson; S R Holmberg; Alan J Williams
A possible molecular mechanism for 'stunning' of the myocardium.
European heart journal 1991;12 Suppl F():25-9.
1991: C W Jiang; Philip A Poole-Wilson; P Collins
Comparison of rabbit coronary arterial relaxation induced by acetylcholine and lemakalim: activation of ATP sensitive potassium channels.
Cardiovascular research 1991;25(11):930-5.
1991: Giuseppe Rosano; D C Lindsay; Philip A Poole-Wilson
Syndrome X: an hypothesis for cardiac pain without ischaemia.
Cardiologia (Rome, Italy) 1991;36(11):885-95.
1991: Sian E Harding; Kenneth T MacLeod; S M Jones; G Vescovo; Philip A Poole-Wilson
Contractile responses of myocytes isolated from patients with cardiomyopathy.
European heart journal 1991;12 Suppl D():44-8.
1991: L A Corr; Philip A Poole-Wilson; G Burnstock
Responses of coronary arteries to neurotransmitters: changes with sexual maturity in the female rabbit.
Journal of cardiovascular pharmacology 1991;18(1):144-50.
1991: Sian E Harding; J M Gurden; Philip A Poole-Wilson
A comparison of contractile function between papillary muscles and isolated myocytes from the same human hearts.
Cardioscience 1991;2(2):141-6.
1991: L Corr; G Burnstock; Philip A Poole-Wilson
Magnesium inhibits the responses to neuropeptide Y in the rabbit coronary artery.
Journal of molecular and cellular cardiology 1991;23(3):231-5.
1991: L Corr; G Burnstock; Philip A Poole-Wilson
Responses of the rabbit epicardial coronary artery to acetylcholine and adrenoceptor agonists.
Cardiovascular research 1991;25(3):256-62.
1991: S R Holmberg; D V Cumming; Y Kusama; D J Hearse; Philip A Poole-Wilson; M J Shattock; Alan J Williams
Reactive oxygen species modify the structure and function of the cardiac sarcoplasmic reticulum calcium-release channel.
Cardioscience 1991;2(1):19-25.
1991: N P Buller; D Jones; Philip A Poole-Wilson
Direct measurement of skeletal muscle fatigue in patients with chronic heart failure.
British heart journal 1991;65(1):20-4.
1990: Philip M Sarrel; D C Lindsay; Philip A Poole-Wilson; P Collins
Hypothesis: inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of pre-eclampsia.
Lancet 1990;336(8722):1030-2.
1990: A J Scriven; D P Lipkin; K M Fox; Philip A Poole-Wilson
Maximal oxygen uptake in severe aortic regurgitation: a different view of left ventricular function.
American heart journal 1990;120(4):902-9.
1990: S M Jones; M S Kirby; Sian E Harding; G Vescova; R B Wanless; L D Dalla Libera; Philip A Poole-Wilson
Adriamycin cardiomyopathy in the rabbit: alterations in contractile proteins and myocyte function.
Cardiovascular research 1990;24(10):834-42.
1990: T Crake; Philip A Poole-Wilson
Calcium exchange in rabbit myocardium during and after hypoxia: role of sodium-calcium exchange.
Journal of molecular and cellular cardiology 1990;22(10):1051-64.
1990: Sian E Harding; S M Jones; P O'Gara; Giorgio Vescovo; Philip A Poole-Wilson
Reduced beta-agonist sensitivity in single atrial cells from failing human hearts.
The American journal of physiology 1990;259(4 Pt 2):H1009-14.
1990: T Crake; D C Lindsay; Philip A Poole-Wilson
Potassium exchange in the human heart: effect of heart rate and myocardial ischemia.
Cardioscience 1990;1(2):119-26.
1990: N P Buller; Philip A Poole-Wilson
Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure.
British heart journal 1990;63(5):281-3.
1990: Sian E Harding; P O'Gara; S M Jones; L A Brown; Giorgio Vescovo; Philip A Poole-Wilson
Species dependence of contraction velocity in single isolated cardiac myocytes.
Cardioscience 1990;1(1):49-53.
1990: A P Fitzpatrick; L M Shapiro; AF Rickards; Philip A Poole-Wilson
Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy.
British heart journal 1990;63(2):114-8.
1990: J S Gibbs; J Keegan; C Wright; Kim M Fox; Philip A Poole-Wilson
Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure.
Journal of the American College of Cardiology 1990;15(1):52-61.
1989: Giorgio Vescovo; Sian E Harding; M Jones; Luciano Dalla Libera; A C Pessina; Philip A Poole-Wilson
Contractile abnormalities of single right ventricular myocytes isolated from rats with right ventricular hypertrophy.
Journal of molecular and cellular cardiology 1989;21 Suppl 5():103-11.
1989: Philip A Poole-Wilson
Regulation of intracellular pH in the myocardium; relevance to pathology.
Molecular and cellular biochemistry 1989;89(2):151-5.
1989: Giorgio Vescovo; S E Harding; S M Jones; Luciano Dalla Libera; A C Pessina; Philip A Poole-Wilson
Comparison between isomyosin pattern and contractility of right ventricular myocytes isolated from rats with right cardiac hypertrophy.
Basic research in cardiology 1989;84(5):536-43.
1989: J S Gibbs; D Cunningham; L M Shapiro; A Park; Philip A Poole-Wilson; Kim M Fox
Diurnal variation of pulmonary artery pressure in chronic heart failure.
British heart journal 1989;62(1):30-5.
1989: J Parameshwar; J H Dambrink; J Sparrow; C Wright; A Park; J Tweed; Philip A Poole-Wilson
A new exercise test for the assessment of heart failure: use of a self powered treadmill.
British heart journal 1989;61(5):421-5.
1989: J S Gibbs; D Cunningham; J Sparrow; Philip A Poole-Wilson; Kim M Fox
Unpredictable zero drift in intravascular micromanometer tipped catheters during long term pulmonary artery pressure recording: implications for catheter design.
Cardiovascular research 1989;23(2):152-8.
1989: Philip A Poole-Wilson
Exercise as a means of assessing heart failure and its response to treatment.
Cardiology 1989;76(5):347-56.
1988: Philip A Poole-Wilson
The origin of symptoms in patients with chronic heart failure.
European heart journal 1988;9 Suppl H():49-53.
1988: Timothy J Bowker; Kim M Fox; F W Cross; Philip A Poole-Wilson; Stephen G Bown; AF Rickards
Perforation thresholds and safety factors in in vivo coronary laser angioplasty.
British heart journal 1988;59(4):429-37.
1988: Timothy J Bowker; F W Cross; Kim M Fox; Philip A Poole-Wilson; Stephen G Bown; AF Rickards
Laser assisted coronary angioplasty.
European heart journal 1988;9 Suppl C():25-9.
1988: D P Lipkin; D A Jones; J M Round; Philip A Poole-Wilson
Abnormalities of skeletal muscle in patients with chronic heart failure.
International journal of cardiology 1988;18(2):187-95.
1988: A J Scriven; D P Lipkin; I S Anand; G C Sutton; Philip A Poole-Wilson
Double-blind, randomised, cross-over comparison of oral captopril and enoximone added to diuretic treatment in patients with severe heart failure.
Journal of cardiovascular pharmacology 1988;11(1):45-50.
1987: A Richardson; J Bayliss; A J Scriven; J Parameshwar; Philip A Poole-Wilson; G C Sutton
Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure.
Lancet 1987;2(8561):709-11.
1987: A J Scriven; D P Lipkin; I S Anand; G C Sutton; Philip A Poole-Wilson
A comparison of hemodynamic effects of one-month oral captopril and enoximone treatment for severe congestive heart failure.
The American journal of cardiology 1987;60(5):68C-71C.
1987: J Bayliss; L Thomas; Philip A Poole-Wilson
Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate.
Journal of cardiovascular pharmacology 1987;9(5):551-4.
1987: R Canepa-Anson; J R Dawson; P Kuan; Philip A Poole-Wilson; G C Sutton; B Cockrill; S R Reuben
Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure.
British journal of clinical pharmacology 1987;23(2):173-81.
1987: J Bayliss; M Norell; R Canepa-Anson; G Sutton; Philip A Poole-Wilson
Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.
British heart journal 1987;57(1):17-22.
1986: J Bayliss; R Canepa-Anson; M Norell; Philip A Poole-Wilson; G Sutton
The renal response to neuroendocrine inhibition in chronic heart failure: double-blind comparison of captopril and prazosin.
European heart journal 1986;7(10):877-84.
1986: D P Lipkin; A J Scriven; T Crake; Philip A Poole-Wilson
Six minute walking test for assessing exercise capacity in chronic heart failure.
British medical journal (Clinical research ed.) 1986;292(6521):653-5.
1986: J Bayliss; R Canepa-Anson; M S Norell; Philip A Poole-Wilson; G Sutton
Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.
British heart journal 1986;55(3):265-73.
1985: J Bayliss; M S Norell; R Canepa-Anson; C Reid; Philip A Poole-Wilson; G Sutton
Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.
British medical journal (Clinical research ed.) 1985;290(6485):1861-5.
1983: J R Dawson; R Canepa-Anson; P Kuan; S R Reuben; Philip A Poole-Wilson; G C Sutton
Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.
British heart journal 1983;50(3):282-9.
1983: J Bayliss; M Norell; R Canepa-Anson; S R Reuben; Philip A Poole-Wilson; G C Sutton
Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.
British heart journal 1983;49(3):214-21.
1982: J R Dawson; J Bayliss; M S Norell; R Canepa-Anson; P Kuan; S Reuben; Philip A Poole-Wilson; G C Sutton
Clinical studies with beta 2 adrenoceptor agonists in heart failure.
European heart journal 1982;3 Suppl D():135-41.
1982: R Canepa-Anson; J R Dawson; W S Frankl; P Kuan; G C Sutton; S Reuben; Philip A Poole-Wilson
Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmias.
European heart journal 1982;3 Suppl D():129-34.
1982: C Ilsley; R Canepa-Anson; C Westgate; S Webb; A Rickards; Philip A Poole-Wilson
Influence of R wave analysis upon diagnostic accuracy of exercise testing in women.
British heart journal 1982;48(2):161-8.
1981: R Canepa-Anson; J R Dawson; P Kuan; C A Warnes; Philip A Poole-Wilson; S R Reuben; G C Sutton
Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failure.
American heart journal 1981;102(3 Pt 2):578-83.
1981: J R Dawson; R Canepa-Anson; P Kuan; N H Whitaker; J Carnie; C Warnes; S R Reuben; Philip A Poole-Wilson; G C Sutton
Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.
British medical journal (Clinical research ed.) 1981;282(6274):1423-6.
1981: C Ilsley; R Canepa-Anson; G Langley; R Foale; Philip A Poole-Wilson; A Rickards
R-wave amplitude and left ventricular volume: changes with nitroglycerine and atrial pacing.
Cardiology 1981;68 Suppl 2():153-60.